関連する実験動画
Updated: Mar 7, 2026

14:57
Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
10.1K
PTEN欠乏がんにおけるクロマチン再構成因子CHD1の合成的本質性
Di Zhao1, Xin Lu1, Guocan Wang1
1Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
Nature
|February 7, 2017
まとめ
研究者らは,PTEN欠乏がんにおける潜在的な治療標的としてCHD1を特定した. CHD1を減らし,腫瘍の成長を抑制し,新しいがん経路と標的発見の枠組みを明らかにした.
科学分野:
- 腫瘍学
- 分子生物学
- 遺伝学
背景:
- 合成死亡率と付随死亡率は,がんの治療標的を特定するための確立された戦略であり,特に腫瘍抑制遺伝子の削除があるがんではそうである.
- 癌ゲノムにおける相互排他的削除パターンのスクリーニングは,合成-致死相互作用を発見するための新しいアプローチを提供します.
研究 の 目的:
- 時々削除されるが,特定の腫瘍抑制剤の欠陥の文脈で不可欠な"合成必須"遺伝子を特定する.
- 特定の腫瘍抑制剤の欠陥のあるがんにおける 潜在的な治療標的として これらの合成必須遺伝子を検証する
主な方法:
- 癌ゲノムの相互排他的削除パターンのスクリーニング
- PTEN欠乏性前立腺がんおよび乳がん細胞系におけるクロマチンヘリゼDNA結合因子CHD1の枯渇研究.
- PTEN-GSK3β-CHD1-β-TrCP経路とCHD1の分解とTNF-NF-κB遺伝子ネットワークの活性化におけるその役割を調査するメカニズム研究.
主要な成果:
- この研究では,PTEN欠乏性がんにおける推定合成必須遺伝子としてCHD1を特定した.
- CHD1の減少は,PTEN欠乏性前立腺がんと乳がんにおける増殖,生存,および腫瘍発生能力を有意に抑制した.
- PTEN欠乏はCHD1の安定化につながり,ヒストンの改変によって腫瘍原性TNF- NF- kB経路を活性化させます.
結論:
- CHD1の調節とTNF- NF- kBネットワークへの影響を含む癌における新しいPTEN経路が解明されました.
- この研究は,特定の腫瘍抑制剤欠乏症のがんにおける"追跡可能な"治療標的の発見のための枠組みを提供し,PTEN欠乏症の腫瘍における有望な標的としてCHD1を強調しています.
関連する概念動画
Abnormal Proliferation
5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Nucleosome Remodeling
11.5K
Nucleosomes are the basic units of chromatin compaction. Each nucleosome consists of the DNA bound tightly around a histone core, which makes the DNA inaccessible to DNA binding proteins such as DNA polymerase and RNA polymerase. Hence, the fundamental problem is to ensure access to DNA when appropriate, despite the compact and protective chromatin structure.
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
11.5K
Epigenetic Regulation
4.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
4.0K
Epigenetic Regulation
34.1K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
34.1K
Inheritance of Chromatin Structures
7.8K
Epigenetics is the study of inherited changes in a cell's phenotype without changing the DNA sequences. It provides a form of memory for the differential gene expression pattern to maintain cell lineage, position-effect variegation, dosage compensation, and maintenance of chromatin structures such as telomeres and centromeres. For example, the structure and location of the centromere on chromosomes are epigenetically inherited. Its functionality is not dictated or ensured by the underlying...
7.8K
Chromatin Modification in iPS Cells
2.3K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
2.3K

